Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coli

Journal Article · · Antimicrobial Agents and Chemotherapy
DOI:https://doi.org/10.1128/AAC.01572-17· OSTI ID:1498302

ABSTRACT

Fosfomycin exhibits broad-spectrum antibacterial activity and is being reevaluated for the treatment of extensively drug-resistant pathogens. Its activity in Gram-negative organisms, however, can be compromised by expression of FosA, a metal-dependent transferase that catalyzes the conjugation of glutathione to fosfomycin, rendering the antibiotic inactive. In this study, we solved the crystal structures of two of the most clinically relevant FosA enzymes: plasmid-encoded FosA3 fromEscherichia coliand chromosomally encoded FosA fromKlebsiella pneumoniae(FosAKP). The structure, molecular dynamics, catalytic activity, and fosfomycin resistance of FosA3 and FosAKPwere also compared to those of FosA fromPseudomonas aeruginosa(FosAPA), for which prior crystal structures exist.E. coliTOP10 transformants expressing FosA3 and FosAKPconferred significantly greater fosfomycin resistance (MIC, >1,024 μg/ml) than those expressing FosAPA(MIC, 16 μg/ml), which could be explained in part by the higher catalytic efficiencies of the FosA3 and FosAKPenzymes. Interestingly, these differences in enzyme activity could not be attributed to structural differences at their active sites. Instead, molecular dynamics simulations and hydrogen-deuterium exchange experiments with FosAKPrevealed dynamic interconnectivity between its active sites and a loop structure that extends from the active site of each monomer and traverses the dimer interface. This dimer interface loop is longer and more extended in FosAKPand FosA3 than in FosAPA, and kinetic analyses of FosAKPand FosAPAloop-swapped chimeric enzymes highlighted its importance in FosA activity. Collectively, these data yield novel insights into fosfomycin resistance that could be leveraged to develop new strategies to inhibit FosA and potentiate fosfomycin activity.

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
UNIVERSITYNIH
OSTI ID:
1498302
Journal Information:
Antimicrobial Agents and Chemotherapy, Journal Name: Antimicrobial Agents and Chemotherapy Journal Issue: 11 Vol. 61; ISSN 0066-4804
Publisher:
American Society for Microbiology
Country of Publication:
United States
Language:
ENGLISH

Similar Records

In Vivo and In Vitro Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant Enterococci
Journal Article · Mon May 21 00:00:00 EDT 2018 · Antimicrobial Agents and Chemotherapy · OSTI ID:1479031

Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens
Journal Article · Sun Jan 13 23:00:00 EST 2019 · Antimicrobial Agents and Chemotherapy · OSTI ID:1497177

Cofactor Specificity of the Bifunctional Alcohol and Aldehyde Dehydrogenase (AdhE) in Wild-Type and Mutant Clostridium thermocellum and Thermoanaerobacterium saccharolyticum
Journal Article · Tue May 26 00:00:00 EDT 2015 · Journal of Bacteriology · OSTI ID:1351568

Related Subjects